Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-02 Hansen Gwenn Chief Scientific Officer Sale −1,098 $11.75 $13K 17,151
2022-05-02 Wolff Stefani EVP and COO Sale −330 $11.75 $4K 632
2022-05-02 van Houte Hans Chief Financial Officer Sale −697 $11.75 $8K 2,189
2022-05-02 Ring Christine General Counsel Sale −660 $11.75 $8K 3,403
2022-04-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,206 18,249
2022-04-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,206 48,102
2022-04-30 Wolff Stefani EVP and COO Option exercise +962 962
2022-04-30 Wolff Stefani EVP and COO Option exercise · Restricted Stock Units −962 14,430
2022-04-30 van Houte Hans Chief Financial Officer Option exercise +2,886 2,886
2022-04-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,886 43,291
2022-04-30 Ring Christine General Counsel Option exercise +1,924 4,063
2022-04-30 Ring Christine General Counsel Option exercise · Restricted Stock Units −1,924 28,861
2022-01-20 SANDS ARTHUR T President, CEO Grant or award · Employee Stock Option (right to buy) +300,000 300,000
2022-01-19 Wolff Stefani EVP and COO Grant or award · Employee Stock Option (right to buy) +34,631 34,631
2022-01-19 Wolff Stefani EVP and COO Grant or award · Restricted Stock Units +15,392 15,392
2022-01-19 van Houte Hans Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +103,894 103,894
2022-01-19 van Houte Hans Chief Financial Officer Grant or award · Restricted Stock Units +46,177 46,177
2022-01-19 Ring Christine General Counsel Grant or award · Employee Stock Option (right to buy) +69,262 69,262
2022-01-19 Ring Christine General Counsel Grant or award · Restricted Stock Units +30,785 30,785
2022-01-19 Hansen Gwenn Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +115,438 115,438

Page 29 of 32 · 632 trades